PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer

Altres ajuts: This study was supported by funds from the NCI Breast SPORE Program (P50-CA58223-09A1), by RO1-CA138255, by the Breast Cancer Research Foundation, and the Sociedad Española de Oncología Médica (SEOM). A. Prat is affiliated to the Medicine PhD Program of the Autonomous University of Barcelona (UAB), Spain.The online version of this article (doi:10.1007/s10549-012-2143-0) contains supplementary material, which is available to authorized users